SEC Form 4 · accession 0001214659-15-000042
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
May Liu
Officer — Chief Accounting Officer
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 19,802 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $1.61 | Dec 30, 2014 | A | 120,000 | A | — | Dec 30, 2024 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1Includes 12,500 acquired under the Issuer's 2010 Employee Stock Ownership Plan on December 31, 2014 and 187 shares of stock acquired through the vesting of restricted stock units, which represent the portion of the Reporting Person's 2010 performance share award.
- F2This stock option vests monthly over four years beginning December 30, 2014 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start and will expire on December 30, 2024.